Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | USP2 | O75604 | 3/20 | 0.35 |
| ▸ | INMT | O95050 | 1/20 | 0.35 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5111613 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL8992014 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL497507 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL8992009 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL23486255 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL8420655 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL23661069 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL11110396 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL14818806 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 | |
| SCHEMBL11082560 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPTUSP2INMTPSMB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9822012-B2 | Molecular sieve Al-SSZ-63 composition of matter and synthesis thereof | CHEVRON U.S.A. INC. (US) | 2017-11-21 | — | — | US | disclosed |
| US-9822012-B2 | Molecular sieve Al-SSZ-63 composition of matter and synthesis thereof | CHEVRON U.S.A. INC. (US) | 2017-11-21 | — | — | US | disclosed |
| US-9822012-B2 | Molecular sieve Al-SSZ-63 composition of matter and synthesis thereof | CHEVRON U.S.A. INC. (US) | 2017-11-21 | — | — | US | disclosed |
| US-20170291822-A1 | MOLECULAR SIEVE AL-SSZ-63 COMPOSITION OF MATTER AND SYNTHESIS THEREOF | CHEVRON U.S.A. INC. (US) | 2017-10-12 | — | — | US | disclosed |
| US-20170291822-A1 | MOLECULAR SIEVE AL-SSZ-63 COMPOSITION OF MATTER AND SYNTHESIS THEREOF | CHEVRON U.S.A. INC. (US) | 2017-10-12 | — | — | US | disclosed |
| US-20170291822-A1 | MOLECULAR SIEVE AL-SSZ-63 COMPOSITION OF MATTER AND SYNTHESIS THEREOF | CHEVRON U.S.A. INC. (US) | 2017-10-12 | — | — | US | disclosed |
| US-6827843-B2 | N-cyclodecyl-N-methyl-pyrrolidinium cation as a structure-directing agent | CHEVRON U.S.A., INC. | 2004-12-07 | — | — | US | disclosed |
| US-6776973-B2 | PREPARED USING N-CYCLODECYL-N-METHYL-PYRROLIDINIUM CATION AS A STRUCTURE-DIRECTING AGENT, | CHEVRON U.S.A. INC. | 2004-08-17 | — | — | US | disclosed |
| US-20040124123-A1 | Hydrocarbon conversion using molecular sieve SSZ-63 | CHEVRON U.S.A. INC. | 2004-07-01 | — | — | US | disclosed |
| US-20040127346-A1 | USING MOLECULAR SIEVE SSZ-63 FOR REDUCTION OF OXIDES OF NITROGEN IN A GAS STREAM | CHEVRON U.S.A. INC. | 2004-07-01 | — | — | US | disclosed |
| US-6733742-B1 | N-CYCLODECYL-N-METHYL-PYRROLIDINIUM CATION AS A STRUCTURE DIRECTING AGENT; SILICON OXIDE AND/OR GERMANIUM OXIDE WITH OXIDES OF ALUMINUN, GALLIUM, IRON, BORON, TITANIUM, INDIUM, AND/OR VANADIUM | CHEVRON U.S.A. INC. | 2004-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040124123-A1 | Hydrocarbon conversion using molecular sieve SSZ-63 | NSD3, HELZ, SPIN3 | ALDH1A1 4839/4885MAPT 3912/4885USP2 2838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.